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Abstract
Background and Objective: Coronary heart disease (CHD) is the leading cause of death, and smoking its strongest
modifiable risk factor. Our aim was to determine the impact of the Spanish 2006 partial smoke-free legislation on acute
myocardial infarction (AMI) incidence, hospitalization and mortality rates, and 28-day case-fatality in Girona, Spain.
Methods: Using a population-based registry (the REGICOR Study), we compared population incidence, hospitalization, and
mortality rates, and 28-day case-fatality in the pre- and post-ban periods (2002–2005 and 2006–2008, respectively) by
binomial regression analysis adjusted for confounding factors. We also analyzed the ban’s impact on the outcomes of
interest using the AMI definitions of the American Heart Association (AHA)/European Society of Cardiology (ESC) and the
World Health Organization (WHO)-Monitoring trends and determinants in cardiovascular diseases (MONICA).
Results: In the post-ban period, AMI incidence and mortality rates significantly decreased (relative risk [RR] = 0.89; 95%
confidence interval [CI] = 0.81–0.97 and RR = 0.82; 95% CI = 0.71–0.94, respectively). Incidence and mortality rates decreased
in both sexes, especially in women, and in people aged 65–74 years. Former and non-smokers (passive smokers) showed
diminished incidence rates. Implementation of the ban was not associated with AMI case-fatality. Models tended to be more
significant with the WHO-MONICA than with the AHA/ESC definition.
Conclusions: The 2006 Spanish partial smoke-free legislation was associated with a decrease in population AMI incidence
and mortality, particularly in women, in people aged 65–74 years, and in passive smokers. These results clarify the
association between AMI mortality and the enactment of a partial smoke-free legislation and reinforce the effectiveness of
smoking regulations in preventing CHD.
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Introduction
Smoking and second-hand smoke (SHS) are major and
preventable public health hazards [1] and risk factors for coronary
heart disease (CHD) [2,3], the single most common cause of death
and morbidity worldwide. Public health authorities have imple-
mented various policies such as smoke-free legislations to reduce
the burden of CHD. Analysis of the effects of smoke-free
legislations in different populations has shown substantial reduc-
tion in hospital admissions for acute coronary syndrome after the
enactment of the ban [4–15].
However, most previous studies used data from hospital-based
registries and only two studies have analyzed the impact of smoke-
free legislations in population-based registries [6,7]. This is
particularly important because about two thirds of fatal acute
myocardial infarction (AMI) events occur before reaching the
hospital [16]. Therefore, a population-based registry should
provide a broader depiction of the disease and of the potential
impact of smoke-free legislations. In addition, only a few studies
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have analyzed the association between smoke-free legislation
enactment and AMI mortality [17–20], with contradictory results.
No study has examined the association between the enactment of a
smoke-free legislation and AMI 28-day case-fatality.
In January 2006, Spain implemented smoking regulations (Law
28/2005) that included a ban on advertising, a reduction in sales
outlets, and a partial smoke-free legislation which banned smoking
in all indoor public places and workplaces but allowed some
exceptions in hospitality venues. Hospitality venues .100 m2
could be smoke-free or have a smoking section up to 30% of the
total area while venues ,100 m2 could decide to be smoke-free or
to allow smoking without restrictions [21]. Studies of the
immediate impact of the 2006 partial smoke-free legislation
reported a decrease in AMI hospitalization rates in Barcelona
from 2004 to 2006 [13], and a decrease in adjusted AMI mortality
rates in Spain from 2004 to 2007 [20]. In January 2011, Spain
passed a new law (Law 42/2010) that amended the previous of
2005 and banned smoking in all workplaces with no exceptions in
the hospitality sector.
The main aim of this study was to analyze the impact of the
2006 Spanish partial smoke-free legislation on AMI incidence,
hospitalization and mortality rates, and 28-day case-fatality in a
population-based registry and a hospital-based registry. The
secondary aims were to analyze the effect of the partial smoke-
free legislation on different subgroups of the population and to
compare results using the AMI definitions of the American Heart
Association (AHA)/European Society of Cardiology (ESC) defini-
tion, in use since 2000, and the World Health Organization
(WHO)-Monitoring trends and determinants in cardiovascular
diseases (MONICA) in this particular setting.
Methods
Ethics statement
The REGICOR study was approved by the IMAS (Institut
Municipal d’Assistencia Sanitaria) Ethics Committee and has been
performed in accordance with the ethical standards laid down in
the 1964 Declaration of Helsinki and its later amendments. No
informed consent was obtained from the participants. The
REGICOR study is a population-based myocardial infarction
registry and one of the requirements of a population registry is to
be exhaustive to guaranty the validity of the incidence estimates
obtained, thus all cases have to be included. To respect and
guarantee the confidentiality of the patients the investigators did
not have access to individual confidential data and the data were
analyzed anonymously.
Study design
This was a before-and-after observational study using a
population-based AMI registry, the REGICOR Study, to analyze
the effect of 2006 Spanish partial smoke-free legislation on AMI
incidence and mortality outcomes. The REGICOR (REgistre GIronı́
del COR; Girona Heart Registry) Study, conducted in six counties
of the Girona province in the north east of Spain, includes a
reference population of residents aged 25 to 74 years [22,23].
There is one reference hospital with a coronary care unit, to which
six community hospitals refer their AMI patients after emergency
treatment.
Case-finding procedures were prospective for registering AMI
patients admitted to the coronary care unit and retrospective in
the community hospitals, accomplished by screening discharge
records of all AMI patients they admitted. All discharges with
International Classification of Diseases (ICD) codes 410–414 (for
the 9th revision) or I20–I25 (for the 10th revision) were reviewed. In
order to include out-of-hospital AMI events, all death certificates
containing suggestive ICD codes (ICD-9: 410–414, 798; or ICD-
10: I20–I25, I513, R960, R961, R98, R99) were investigated. To
avoid case duplication the information from all sources was linked
and verified by the researchers.
Event classification
Each event was classified according to two different algorithms,
applying the AHA/ESC [24] and the WHO-MONICA study
Table 1. Characteristics of patients with AMI in Girona Province (Spain), in 2002–2008, according to the AHA/ESC AMI definition.
Population-based registry cases Hospital-based registry cases
Men Women Total P value Men Women Total P value
Events, n (%)
All cases 2895 (78.18) 808 (21.82) 3703 (100) 2341 (77.72) 671 (22.28) 3012 (100)
35–64 years 1711 (59.10) 297 (36.80) 2008 (54.20) ,0.01 1450 (61.90) 262 (39.00) 1712 (56.80) ,0.01
65–74 years 1184 (40.90) 511 (63.20) 1695 (45.80) ,0.01 891 (38.10) 409 (61.00) 1300 (43.20) ,0.01
Cardiovascular risk factors
Age (years, mean (SD)) 60.87 (9.90) 64.67 (8.89) 61.25 (9.86) ,0.01 59.69 (9.97) 64.38 (9.01) 60.73 (9.96) ,0.01
Smoking, n (%)
Current smoker 1211 (47.47) 131 (17.96) 1342 (40.91) ,0.01 1121 (49.17) 127 (19.48) 1248 (42.56) ,0.01
Former smoker 870 (34.20) 31 (4.25) 901 (27.46) ,0.01 763 (33.46) 29 (4.45) 792 (27.01) ,0.01
Never smoker 470 (18.42) 567 (77.77) 1037 (31.61) ,0.01 396 (17.37) 496 (76.07) 892 (30.42) ,0.01
Arterial hypertension, n (%) 1491 (58.90) 535 (72.80) 2026 (62.00) ,0.01 1339 (59.40) 480 (73.80) 1819 (62.60) ,0.01
Diabetes, n (%) 806 (32.50) 307 (42.10) 1113 (34.70) ,0.01 688 (31.20) 274 (42.20) 962 (33.70) ,0.01
Hypercholesterolemia, n (%) 1363 (55.90) 380 (53.70) 1743 (55.40) 0.31 1245 (57.60) 355 (56.60) 1600 (57.40) 0.68
Previous AMI, n (%) 558 (19.30) 140 (17.30) 698 (18.80) 0.18 430 (18.40) 121 (18.00) 551 (18.30) 0.93
AMI Case-fatality, n (%) 691 (23.86) 200 (24.75) 891 (24.06) 0.64 140 (6.00) 64 (9.50) 204 (6.80) ,0.01
AMI acute myocardial infarction, AHA American Heart Association, ESC European Society of Cardiology, SD Standard deviation.
doi:10.1371/journal.pone.0053722.t001
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definitions [16]. Both definitions are based on ECG findings,
patient symptoms, and cardiac biomarkers. Data on symptoms,
electrocardiographic variables and biomarkers were obtained from
clinical records. Creatine-phosphokinase and troponins were used
as biomarkers of myocardial necrosis in the WHO-MONICA and
the AHA/ESC definitions, respectively. WHO/MONICA select-
ed events were: fatal and non-fatal definite AMI, fatal possible
AMI, and fatal cases with insufficient information [16]. Equivalent
events were selected using the AHA/ESC algorithm: fatal and
non-fatal definite AMI, fatal probable AMI, fatal possible
coronary event, definite ischemic heart death, possible ischemic
heart death, and fatal cases with insufficient information [24]. Two
consecutive events in the same participant were considered as
different events if the time between them exceeded 28 days.
Study period
We included all registered AMI events from January 1, 2002
through December 31, 2008 from people aged 35–74 years
residing in the study area. Two study periods were established: a 4-
year pre-ban period (2002–2005) and a 3-year post-ban period
(2006–2008). AMI events occurring in 2001 were excluded to
diminish the impact of the AHA/ESC AMI redefinition and its
gradual implementation on AMI incidence,
Study variables
For this analysis the following variables were selected: age, sex,
smoking, arterial hypertension, diabetes, hypercholesterolemia,
and event-related variables such as symptoms, electrocardiograph-
ic variables, and biomarkers of myocardial necrosis. Data on
hypercholesterolemia, hypertension, and smoking status were
obtained by trained personnel using WHO-MONICA question-
naires. Current smokers were defined as persons who smoked
more than 1 cigarette/day or reported quitting within the previous
12 months, while persons who had never smoked or smoked less
than 1 cigarette/day were considered as non-smokers. Former
smokers were defined as persons who had quit smoking more than
12 months before the event. Data on diabetes were obtained using
WHO-MONICA questionnaires in addition to glucose values and
treatment information obtained from clinical records. Validity of
Table 2. Annual AMI incidence, hospitalization and mortality rates and 28-day case-fatality by age group or sex, in 2002–2008,
according to the AHA/ESC AMI definition.
Crude Cumulative AMI incidence rate (6100.000/year)
2002 2003 2004 2005 2006 2007 2008
Total 201.37 202.35 185.89 173.35 163.97 161.16 175.15
Women 87.84 108.76 90.34 68.91 67.58 69.44 70.39
Men 312.34 293.46 278.85 274.24 255.89 248.49 275.18
35–64 years 124.88 120.21 122.13 109.92 110.52 112.39 127.84
65–74 years 513.56 549.63 473.48 479.83 432.42 416.70 418.61
Crude AMI hospitalization rate (6100.000/year)
2002 2003 2004 2005 2006 2007 2008
Total 158.69 162.02 155.72 144.90 132.91 130.12 142.71
Women 74.96 86.85 74.68 58.57 58.96 54.00 59.76
Men 240.54 235.19 234.56 228.31 203.44 202.58 221.91
35–64 years 107.64 101.95 104.98 95.62 91.90 94.84 109.24
65–74 years 367.10 415.98 384.58 383.07 338.9 314.96 314.95
Crude AMI Mortality rate (6100.000/year)
2002 2003 2004 2005 2006 2007 2008
Total 56.14 51.85 45.60 37.58 39.46 35.12 39.57
Women 19.69 31.39 27.03 15.16 15.24 16.72 14.61
Men 91.78 71.77 63.66 59.24 62.55 52.64 63.41
35–64 years 21.44 23.15 23.14 18.39 21.33 18.67 22.08
65–74 years 197.82 173.17 146.88 130.32 130.51 121.29 129.57
AMI 28-day case-fatality (%)
2002 2003 2004 2005 2006 2007 2008
Total 27.88 25.62 24.53 21.68 24.06 21.79 22.59
Women 22.41 28.86 29.92 22.00 22.55 24.07 20.75
Men 29.38 24.46 22.83 21.6 24.44 21.18 23.04
35–64 years 17.16 19.26 18.95 16.73 19.3 16.61 17.27
65–74 years 38.52 31.51 31.02 27.16 30.18 29.11 30.95
AMI acute myocardial infarction, AHA American Heart Association, ESC European Society of Cardiology.
doi:10.1371/journal.pone.0053722.t002
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the WHO-MONICA questionnaires compared with clinical
records has already been described [25,26].
Statistical analysis
We computed crude annual rates (6100,000 inhabitants) of
population AMI incidence, AMI hospitalization, and population
AMI mortality by age group (35–64 and 65–74 years) and sex. We
also calculated AMI 28-day case-fatality. Separate calculations
were done for events obtained with the AHA/ESC and the WHO-
MONICA definitions. The rate denominator was taken from
annual population distributions by sex and 5-year age groups
published by the Statistical Institute of Catalonia [27].
Prior to conduct multivariate regression analyses, we analyzed
data over-dispersion undertaking a likelihood ratio test where the
null hypothesis was that the restriction implicit in the Poisson
regression model was true (mean = variance). As this test was
extremely significant (p-value = 2.2*1026), we rejected the null
hypothesis and assessed the effect of the partial smoke-free
legislation on AMI incidence, mortality, and case-fatality by
negative binomial regression analysis. The outcome variable was
AMI events per quarter (for incidence models) or AMI fatal cases
per quarter (for mortality and case-fatality models). The following
predictor variables were included: age (categorized as 35–64 or
65–74 years), sex, and ban status (categorized as pre- or post-
enactment). At-risk population by year, age group, and sex was
included in the models as the offset variable in order to model the
rate of events. In case-fatality models, at-risk events by year, age
group, and sex were used as the offset variable. In addition, the
models were adjusted for the existing trend and for seasonality. To
adjust for the existing trend, we first assessed non-linearity of the
existing time trend graphically and using a p-spline variable in an
additive negative binomial regression model. As the graphs did not
show a non-linear behavior and the spline variable was not
significant (p.0.05), we used a linear variable to account for the
existing trend. In order to adjust for seasonality, we used sine and
cosine harmonic terms as previously described [7,28]. The two
harmonic terms that displayed the best adjustment based on the
Akaike Information Criterion were selected: sine(v*quarter) and
cosine(v*quarter), where v= 2p/4. Relative risks and 95%
confidence interval (CI) were obtained for each variable in the
model.
We performed stratified analysis by age group, sex, and smoking
status. For the latter, an approximate at-risk population served as
the offset variable. This at-risk population was calculated using the
percentage of smokers, non-smokers, and former smokers from
two cross-sectional analyses in the same area in 2000 and 2005
[29]. Former and non-smokers were grouped in the same category
as passive smokers.
Figure 1. Annual AMI incidence and mortality crude rates by sex and age group. Time trend of the 2002–2008 AMI incidence and mortality
crude rates according to the AHA/ESC AMI definition. Annual rates are plotted in the middle of each year. A vertical bar in 2006 indicates the start of
the partial smoke-free legislation. Upper left panel: AMI incidence in women, upper right panel: AMI mortality in women, lower left panel: AMI
incidence in men, lower right panel: AMI mortality in men. Abbreviations: AMI acute myocardial infarction, AHA American Heart Association, ESC
European Society of Cardiology.
doi:10.1371/journal.pone.0053722.g001
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To account for the missing values present in the smoking status
variable we conducted a multiple imputation sensitivity analysis.
Briefly, missing values were imputed using the following variables:
age, sex, smoking status, hypertension, diabetes, hypercholester-
olemia, previous AMI, vital status at 28 days, year and quarter.
We obtained 20 multiple imputed databases for each AMI
definition and we run in each one the described negative binomial
regression model for smokers and passive smokers. Then, we
calculated the global RR estimates and 95% confidence interval
for each smoking group and definition.
Data analyses were performed using version 2.14.0 of the R
statistical program (R Development Core Team (2011). R: A
language and environment for statistical computing. R Foundation
for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0,
URL http://www.R-project.org/).
Results
According to the AHA/ESC definition, a total of 3,703 AMI
cases occurred in residents of the studied area between 2002 and
2008. Of those, 3,012 (81.3%) were admitted to hospital, and
2,142 of all AMI events (57.8%) occurred before the 2006 Spanish
partial smoke-free legislation enactment. The characteristics of the
overall population and of hospital-based cases are shown in
Table 1, stratified by sex. Women were older and less likely than
men to be smokers but with a higher proportion of diabetes and
hypertension. These differences were observed at both the
population and hospital levels. Hospital case-fatality was higher
Table 3. RR and 95% CI for AMI incidence comparing the period after to the period before the 2006 partial smoke-free legislation
enactment, according to both AHA/ESC and WHO-MONICA AMI definitions.
Population-based registry events Hospital-based registry events
Number of events RR (95% CI) Number of events RR (95% CI)
AHA/ESC
All 3703 0.89 (0.81–0.97)* 3011 0.89 (0.81–0.98)*
Women 808 0.82 (0.70–0.96)* 670 0.82 (0.70–0.96)*
Men 2895 0.93 (0.86–0.99)* 2341 0.93 (0.85–1.01)
,65years 2008 0.98 (0.89–1.07) 1712 0.96 (0.87–1.06)
$65years 1695 0.82 (0.74–0.91)* 1299 0.83 (0.74–0.93)*
Smokers 1342 0.94 (0.83–1.06) ---- ----







All 3159 0.85 (0.77–0.94)* 2435 0.84 (0.77–0.93)*
Women 633 0.76 (0.64–0.90)* 484 0.75 (0.62–0.91)*
Men 2526 0.89 (0.82–0.97)* 1951 0.88 (0.80–0.97)*
,65years 1741 0.94 (0.85–1.04) 1436 0.92 (0.83–1.02)
$65years 1418 0.78 (0.70–0.87)* 999 0.77 (0.67–0.88)*
Smokers 1173 0.91 (0.80–1.04) ---- ----
Passive smokers 1579 0.78 (0.69–0.89)* ---- ----
MI Analysis
Smokers 0.91 (0.80–1.04)
Passive smokers 0.82 (0.72–0.92)*
Results from negative binomial regression analysis or multiple imputation (MI) analysis,
*p-value,0.05.
RR relative risk, CI confidence interval, AMI acute myocardial infarction, AHA American Heart Association, ESC European Society of Cardiology, WHO World Health
Organization, MONICA Monitoring Trends and determinants in Cardiovascular diseases.
doi:10.1371/journal.pone.0053722.t003
Table 4. RR and 95% CI for AMI mortality and 28-day case-
fatality comparing the period after to the period before the
2006 partial smoke-free legislation enactment, according to





events RR (95% CI) RR (95% CI)
All 891 0.82 (0.71–0.94)* 0.93 (0.81–1.06)
Women 200 0.72 (0.52–0.97)* 0.90 (0.67–1.21)
Men 691 0.85 (0.72–0.99)* 0.93 (0.80–1.09)
,65years 359 0.94 (0.76–1.17) 0.97 (0.78–1.20)
$65years 532 0.74 (0.62–0.89)* 0.90 (0.75–1.08)
Results from negative binomial regression analysis.
*p-value,0.05.
RR relative risk, CI confidence interval, AMI acute myocardial infarction, AHA
American Heart Association, ESC European Society of Cardiology.
doi:10.1371/journal.pone.0053722.t004
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in women than in men. Demographic characteristics were similar
when the WHO-MONICA AMI definition was used (Table S1).
Table 2 shows the following annual crude rates using AHA/
ESC-defined events: population AMI incidence, AMI hospitaliza-
tion, and AMI mortality (6100,000) and 28-day AMI case-fatality,
stratified by sex and age group from 2002 to 2008. Similar rates
were found using the WHO-MONICA definition (Table S2).
Time trends of crude incidence and mortality rates (according to
the AHA/ESC AMI definition) for each sex and age group from
2002 to 2008 are presented in Figure 1.
In the negative binomial regression analysis we observed a
decrease in population AMI incidence in the post-ban period
(Relative risk [RR]: 0.89; 95% CI: 0.81–0.97) using the AHA/
ESC definition. This decrease was particularly significant among
women (RR: 0.82), people aged 65–74 years (RR: 0.82) and
passive smokers (RR: 0.85) (Table 3, upper left panel). When
selecting hospital events only, the same general trend in AMI
incidence emerged (RR: 0.89; 95% CI: 0.81–0.98), particularly
significant for women (RR: 0.82) and people aged 65–74 years
(RR: 0.83) (Table 3, upper right panel). Similar although slightly
higher effects were observed when the WHO-MONICA definition
was used (Table 3, lower panels). Estimates for smokers and
passive smokers were also obtained by multiple imputation analysis
to minimize the impact of missing data and similar results were
observed (Table 3).
Using the AHA/ESC AMI definition, we found a general
decrease in AMI population mortality in the post-ban period (RR:
0.82; 95% CI: 0.71–0.94), particularly significant for women (RR:
0.72) and people aged 65–74 years (RR: 0.74) (Table 4). Due to
the inclusion of the same cases when using the AHA/ESC or the
WHO-MONICA AMI definitions, the same AMI population
mortality results were obtained with both definitions (Table 4,
Table S3). In the case-fatality analysis, using all population events
and the AHA/ESC AMI definition, we found a non-significant
decrease in the post-ban period (Table 4). The association between
the 2006 Spanish partial smoke-free legislation enactment and
hospital-based mortality and 28-day case-fatality could not be
analyzed due to an insufficient number of events to run the
models. Due to the same reason, stratified analysis by smoking
status could not be conducted in the hospital-based sample.
Discussion
The results of this population-based study show a decline in
crude population AMI incidence and hospitalization in Girona
Province after the 2006 Spanish partial smoke-free legislation
enactment. This decrease was more pronounced among women,
people aged 65–74 years and passive smokers. We also found a
significant decrease in AMI mortality in women and people aged
65–74 years. However, no association was found between the
partial smoke-free legislation enactment and AMI case-fatality.
The association between the implementation of a total smoke-
free legislation and a reduction in hospitalization and population
AMI incidence has already been described. Total smoke-free
legislations have been estimated to decrease AMI hospitalization
by 8–19% [30–33]. A lower decrease in hospital admissions is
expected after the implementation of a partial smoke-free
legislation, as this type of law will still allow smoking in certain
places [33]. Our results show 11% decrease in AMI incidence and
hospitalizations, similar to a recent report that showed 8.6%
decrease in hospital admissions for AMI after a partial smoke-free
legislation in Germany [34]. One possible explanation our
estimate is not lower than the one reported from meta-analyses
from total smoke-free legislations could be the duration of the post-
ban period. We have included a 3-year post-ban period, one of the
largest to date, and it has already been shown, that the larger the
post-ban period, the larger the reduction in AMI incidence
[30,32,34].
Most of the previous studies that analyzed the effect of the
implementation of smoke-free legislation, used hospital-based AMI
registries. Only two Italian studies used population-based registries
[6,7], with contradictory results: one reported a reduction in acute
coronary events in Rome [6] and the other showed no association
in the Tuscany population [7]. Gasparrini et al. [7] pointed out
that the inconsistency between studies could be partially related to
differences in the definition of the statistical model. Estimation of
the effect of the bans is sensitive to the definition of the statistical
model used to analyze the data, specifically the inclusion of the
AMI incidence rate trend and the assumption of linearity of this
trend. To prevent this potential bias, we tested the linearity of AMI
incidence during the analyzed period, included an adjustment for
the linear trend as appropriate, and also adjusted for seasonality.
Previous studies have yielded contradictory results regarding the
effect of smoke-free legislations on AMI incidence and hospital-
ization rates by sex. Some described a higher decrease in men
[6,12], while others found a higher decrease in women [4,9] or
similar results in men and women [5,8,10]. Our study supports a
higher decrease in AMI incidence and hospitalization rates in
women than in men. It should be noted that the population
incidence of AMI in women of Girona is among the lowest rates in
the world [35]. The greater benefit in this population could be
related to women’s higher sensitivity to tobacco smoke compared
to men. It has also been shown that smoking has a larger
detrimental impact on myocardial infarction in women than in
men [36,37]. A plausible biological explanation for women’s
higher sensitivity to tobacco smoke is the alteration of lipid
metabolism through the anti-estrogenic effect of smoking [38–41].
Estrogens have a beneficial effect on LDL- and HDL-cholesterol
metabolism providing a protective effect against myocardial
infarction in women [40,41]. However, women who smoke are
relatively estrogen deficient and have decreased levels of HDL-
cholesterol [37,38]. Our age group results, showing a larger effect
in people aged .64 years, do not concur with previous studies
showing a stronger AMI incidence/hospitalization decrease in
people aged ,60 or ,70 years [4–6,10]. We think that several
factors are contributing to this difference. First, the 2006 partial
smoke-free legislation banned smoking in all indoor public places
and workplaces but allowed exceptions in hospitality venues.
People aged 35–64 years will probably spend much more time at
the places where smoking was still allowed (restaurants, bars,
discos, etc) than people aged 65–74 years. Second, smoking sums
up to the other risk factors, which are more prevalent in people
aged 65–74 years. People aged 65–74 years also contribute more
to the total number of AMI events than the 35–64 years group.
Thus, a reduction in SHS exposure in the older age group would
have a more profound effect, as this age group is at higher risk,
and a reduction in one of the more significant risk factors would
avoid a large number of cases.
In accordance with previous studies [8,10,11], we observed a
decrease in AMI incidence/hospitalization rates among passive
smokers, while no effect was observed in the smokers subgroup.
Spanish partial smoke-free legislation led to a reduction in SHS
exposure [42,43], with a median decrease in nicotine concentra-
tion ranging from 60.0% in public places to 97.4% in private
spaces, 96.7% in bars and restaurants that became smoke-free,
and 88.9% in the no-smoking zones of venues with separate spaces
for smokers [42]. Moreover, significant reductions on SHS were
seen at individual [44] and population level [45]. However, no
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changes were seen neither in salivary cotinine concentration nor in
self-reported exposure to SHS in workers at hospitality venues
where smoking was not totally banned [44]. Reduction in SHS
exposure has also been reported in other populations after a
smoke-free legislation [46]. All these data suggest that reduced
SHS exposure was the fundamental underlying factor explaining
the health effects of the smoke-free legislation.
Our results also showed an association between the Spanish
partial smoke-free legislation and a reduction in AMI mortality,
particularly in the population aged 65–74 years. Four studies have
analyzed AMI mortality during a smoke-free legislation enact-
ment, 3 in the USA [17–19] and 1 in Spain [20], showing a
reduction in AMI mortality only when a post-ban period longer
than 2 years was considered [17,20]. Our study analyzes this trend
over the longest post-ban period reported to date and contributes
to the evidence of an association between reduced AMI mortality
and the enactment of a smoke-free legislation. We also found a
non-significant decrease in AMI case-fatality after the partial
smoke-free legislation enactment, indicating that the decrease in
AMI mortality is mainly due to the decrease in incidence.
The effect sizes of the reported associations are very important
from a public health perspective. The post-ban 18% AMI
mortality decrease observed in the population aged 35–74 years
is comparable with the reported effect of blood pressure control on
coronary heart disease mortality in the 1988–2005 period in Spain
[47].
To avoid the effect of including different definitions of AMI over
time, we adhered to the new AHA/ESC definition algorithms [24]
and excluded 2001 events to avoid the effect of the gradual
implementation of the new definition. In parallel we used the
classical WHO-MONICA AMI definition [16], which ignores the
troponin values. We observed that although the results are
concordant, the effect of the 2006 Spanish partial smoke-free
legislation was slightly higher when using the latter definition. This
difference could explain some of the inconsistencies observed in
previous reports.
Our study has several strengths. First, we used population-based
data drawn from an AMI registry operating since 1990, which
included all hospitalized cases and out-of-hospital deaths. Second,
the availability of individual patient-level information such as
smoking status permitted us to analyze subgroups of the
population. Third, the present study is the first to present a
parallel analysis using both AHA/ESC and WHO-MONICA
AMI definitions. This approach increases the robustness of our
results, bypassing the impact of using the AHA/ESC AMI
redefinition alone, which could have introduced a bias. Finally,
our data were collected with identical methods over a long pre-
and post-ban period, increasing the stability of the estimations.
Our study also has a number of limitations that should be
considered. First, due to the ecological nature of the study, no
causal relationship can be inferred between the implementation of
the 2006 Spanish partial smoke-free legislation and the reduction
in AMI incidence and mortality. Second, unmeasured potential
confounding factors, such as patient comorbidities and AMI case
severity, other activities affecting smoking behavior, changes in
AMI prevention and treatment strategies, and changes in air
quality may have operated together with the partial smoke-free
legislation introduced in 2006. Third, the study does not include
direct observations on SHS exposure and consequently, despite
the reported statistical associations, it is not possible to confirm a
reduction in individual SHS exposure during the months following
the ban enactment.
Conclusions
The Spanish 2006 partial smoke-free legislation was associated
with a reduction in AMI population incidence, mortality, and
hospitalization rates but was not associated with AMI case-fatality
in Girona Province. These results support the effectiveness of
smoking regulations as public health interventions that prevent
CHD, particularly in passive smokers. Further studies are needed
to confirm the impact and effectiveness of the 2011 Spanish total
smoke-free legislation.
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